ERIS Lifesciences Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹745.72Cr |
Net Profits | ₹91.59Cr |
Net Profit Margins | 12.28% |
Highlights
Revenue:
ERIS Lifesciences Ltd’s revenue jumped 46.57% since last year same period to ₹745.72Cr in the Q2 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 3.38% jump in its revenue since last 3-months.
Net Profits:
ERIS Lifesciences Ltd’s net profit fell -25.8% since last year same period to ₹91.59Cr in the Q2 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 10.11% jump in its net profits since last 3-months.
Net Profit Margins:
ERIS Lifesciences Ltd’s net profit margin fell -49.37% since last year same period to 12.28% in the Q2 2024-2025. On a quarterly growth basis, ERIS Lifesciences Ltd has generated 6.51% jump in its net profit margins since last 3-months.
